financetom
Business
financetom
/
Business
/
BrightSpring Health to Divest Community Living Business for $835 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BrightSpring Health to Divest Community Living Business for $835 Million
Jan 21, 2025 3:07 AM

05:53 AM EST, 01/21/2025 (MT Newswires) -- BrightSpring Health Services ( BTSG ) said Monday it will sell its Community Living division, including ResCare Community Living, to Sevita for $835 million in cash.

Post-divestiture, the company said it would focus on Home Health and Hospice, Personal Care, Rehabilitation Services, and Primary Care.

The company expects the divesture would lead to operational efficiencies and a more synergistic service portfolio, boosting revenue and EBITDA growth.

Proceeds from the deal, expected to close in 2025, will primarily be used for debt reduction, improving its balance sheet and lowering interest expenses, the company said.

For 2024, BrightSpring said it expects net revenue to increase by 26.9% to 28% to $11.20 billion to $11.30 billion compared with a year earlier.

Analysts polled by FactSet expected $11.18 billion.

For 2025, which excludes the Community Living business and the effects of any future closed acquisitions, the company expects net revenue between $11.5 billion and $12 billion, a 14.4% to 19.3% increase over 2024.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Marinus Pharmaceuticals Shares Plunge as Phase 3 Trial of Ganaxolone Fails to Meet Goal; Plans to Cut Costs, Explore Alternatives
Marinus Pharmaceuticals Shares Plunge as Phase 3 Trial of Ganaxolone Fails to Meet Goal; Plans to Cut Costs, Explore Alternatives
Oct 25, 2024
03:08 PM EDT, 10/24/2024 (MT Newswires) -- Marinus Pharmaceuticals ( MRNS ) shares plunged nearly 82% in recent Thursday trading after the company said its phase 3 trial of oral ganaxolone failed to meet its main goal and announced plans to reduce costs and explore alternatives for the business. Marinus was studying the drug as a treatment for seizures associated...
US court blocks Tapestry's $8.5 billion acquisition of rival Capri
US court blocks Tapestry's $8.5 billion acquisition of rival Capri
Oct 25, 2024
NEW YORK, Oct 24 (Reuters) - A U.S. judge blocked the pending $8.5 billion merger of U.S. handbag and accessories maker Tapestry and Capri on Thursday, a victory for the U.S. Federal Trade Commission in an industry where merger challenges are rare. The FTC argued at an eight-day trial in New York that the merger would eliminate fierce head-to-head competition...
Deckers Outdoors raises annual sales forecast on strong demand for Hoka shoes
Deckers Outdoors raises annual sales forecast on strong demand for Hoka shoes
Oct 25, 2024
Oct 24 (Reuters) - Deckers Outdoor ( DECK ) beat Wall Street estimates for second-quarter results and raised its annual sales forecast on Thursday, as its brands such as UGG boots and Hoka running shoes continue to resonate with customers. The company's shares were up 8.5% at $164.80 after the bell, set to add to the about 35% gain so...
--L3Harris Technologies Lifts Full-Year 2024 Adjusted Segment Operating Margin Guidance to 15.5%
--L3Harris Technologies Lifts Full-Year 2024 Adjusted Segment Operating Margin Guidance to 15.5%
Oct 25, 2024
04:44 PM EDT, 10/24/2024 (MT Newswires) -- Price: 254.00, Change: +9.83, Percent Change: +4.03 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved